Shilpa Medicare is currently trading at Rs. 419.30, up by 2.95 points or 0.71% from its previous closing of Rs. 416.35 on the BSE.
The scrip opened at Rs. 421.05 and has touched a high and low of Rs. 423.95 and Rs. 418.00 respectively. So far 4738 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 670.95 on 22-Jul-2021 and a 52 week low of Rs. 380.35 on 07-Mar-2022.
Last one week high and low of the scrip stood at Rs. 428.70 and Rs. 392.75 respectively. The current market cap of the company is Rs. 3632.23 crore.
The promoters holding in the company stood at 50.01%, while Institutions and Non-Institutions held 16.40% and 33.59% respectively.
Shilpa Medicare has received GMP certificate from MOH-Russia for its API facility (unit-1) located at Raichur, Karnataka. The facility was audited by the agency on February 17, 2022, February 18, 2022 and February 21, 2022. The facility involves in manufacturing, testing, packing, storage of chemically synthesized nonsterile drug substances for human use.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
